Eusol Biotech Co.,Ltd. (TPEX:6652)
Taiwan · Delayed Price · Currency is TWD 1.960
0.00 (0.00%)
Apr 9, 2026, 2:59 PM CST
Eusol Biotech Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 2.08 | - | - | - | - | |
Cost of Revenue | 1.41 | - | - | - | - |
Gross Profit | 0.67 | - | - | - | - |
Selling, General & Admin | 15.44 | 15.03 | 16.72 | 24.38 | 24.89 |
Research & Development | 32.32 | 26.08 | 24.76 | 52.38 | 97.88 |
Operating Expenses | 47.76 | 41.1 | 41.48 | 76.76 | 122.77 |
Operating Income | -47.1 | -41.1 | -41.48 | -76.76 | -122.77 |
Interest Expense | -0.13 | -0.08 | -0.14 | -0.22 | -0.22 |
Interest & Investment Income | 5.96 | 5.94 | 4.63 | 2.01 | 0.72 |
Currency Exchange Gain (Loss) | -0.6 | 1.65 | -0.37 | 0.01 | -0.2 |
Other Non Operating Income (Expenses) | 0.34 | 0.4 | 0.49 | 0.74 | -1.12 |
EBT Excluding Unusual Items | -41.52 | -33.19 | -36.87 | -74.23 | -123.58 |
Gain (Loss) on Sale of Investments | - | - | -12.45 | - | - |
Gain (Loss) on Sale of Assets | 1.07 | 0.28 | 0.2 | 113.58 | - |
Asset Writedown | - | - | - | -51.58 | - |
Other Unusual Items | 0.03 | - | - | -0.06 | - |
Pretax Income | -40.42 | -32.92 | -49.12 | -12.29 | -123.58 |
Income Tax Expense | - | -2.37 | 2.49 | 6.02 | -0.27 |
Earnings From Continuing Operations | -40.42 | -30.55 | -51.61 | -18.31 | -123.31 |
Net Income | -40.42 | -30.55 | -51.61 | -18.31 | -123.31 |
Net Income to Common | -40.42 | -30.55 | -51.61 | -18.31 | -123.31 |
Shares Outstanding (Basic) | 137 | 137 | 137 | 137 | 134 |
Shares Outstanding (Diluted) | 137 | 137 | 137 | 137 | 134 |
Shares Change (YoY) | - | - | - | 2.21% | 7.23% |
EPS (Basic) | -0.30 | -0.22 | -0.38 | -0.13 | -0.92 |
EPS (Diluted) | -0.30 | -0.22 | -0.38 | -0.13 | -0.92 |
Free Cash Flow | -34.98 | -32.99 | -43.1 | -52.88 | -89.45 |
Free Cash Flow Per Share | -0.26 | -0.24 | -0.32 | -0.39 | -0.67 |
Gross Margin | 32.16% | - | - | - | - |
Operating Margin | -2267.45% | - | - | - | - |
Profit Margin | -1945.88% | - | - | - | - |
Free Cash Flow Margin | -1684.35% | - | - | - | - |
EBITDA | -46.28 | -40.02 | -39.86 | -56.96 | -99.3 |
D&A For EBITDA | 0.81 | 1.09 | 1.62 | 19.8 | 23.47 |
EBIT | -47.1 | -41.1 | -41.48 | -76.76 | -122.77 |